Cerebral malaria causes several deaths every year. Global metabolic alteration, speci cally hypoglycemia and lactic acidosis are hallmarks of severe malaria. Glucose being the major fuel source for the brain, it is important to understand cerebral glucose utilization in the host during cerebral complications of the disease that may have a signi cant role in cerebral pathogenesis. We have used 13 C NMR spectroscopy to understand glucose utilization in the brain and liver of mice with cerebral malaria (CM), noncerebral malaria (NCM), and in control mice. Animals were challenged with intravenous glucose bolus followed by metabolic pro ling of brain and liver extracts. Our result suggests a di erential glucose utilization in the malaria group with respect to that of controls, while no di erence between CM and NCM.
Introduction
Malaria is a global threat that is caused by intraerythrocytic stages of parasites of Plasmodium sp. [1] . e parasitized RBCs consume more glucose than the normal RBCs [2] . e rate of glucose utilization by these cells is also higher than the normal RBCs [3, 4] . Intraerythrocytic Plasmodium parasites lack gluconeogenic enzyme, fructose 1,6 biphosphatase [5] and glycogenolytic enzymes [6] , relying on host RBCs to meet for glucose requirements [7] . Both glycolysis and TCA cycle operate in Plasmodium sp. [8] as ATP generation pathways. However, glycolysis seems to be the major pathway in mammalian and rodent host contrary to TCA cycle in parasites. Glucose uptake from the host by parasites lead to hypoglycemia [9] and hyperlactemia [10] and are reported as major features of severe malaria. Hypoglycemia is also attributed to malabsorption of glucose, cytokine induced gluconeogenesis, and increased tissue metabolism [11] . Interestingly, occurrence of pathophysiological features such as hypoglycemia and lactic-acidosis appears to be a function of disease severity and not cerebral complications [12] [13] [14] [15] [16] [17] . However, it is unknown if glucose utilization in a major metabolic tissue such as liver and brain operate di erentially under CM and NCM conditions. Glucose is the major source of energy in the brain [18] [19] [20] and energy metabolism may have a key role to play in the pathophysiology of CM. us, it is important to understand how glucose is utilized in brain once the cerebral symptoms developed. Liver, on the other hand is one of the major sites of metabolic processes and is the primary regulatory site for blood glucose homeostasis [21] . Previous studies from our group have established signi cant perturbation in hepatic and cerebral glucose metabolism [7, 14, 15] in murine cerebral and noncerebral malaria. However, such studies were performed using an untargeted metabolomics approach that provided a snapshot of metabolic status [22, 23] . While such approaches are useful to delineate biomarkers and ngerprints of the tissues under certain perturbed conditions, they do not provide speci c pathway level information of precursor utilization. Isotope tracing strategies using 13 C NMR spectroscopy could be used to generate pathway level information by tracing metabolite isotopomers. In this report, we have used 13 C NMR spectroscopy to calculate the turnover of various metabolites from isotopically labeled glucose in the brain and liver. 
Materials and Methods

Animal Experiments.
Twenty young adult (6-8 weeks, weighing 24-25 g) female C57BL/6 mice were housed in 5 cages (5 mice per cage) under 22 ± 2°C and 12-hour day/night cycle. ey had free access to standard food pellets and water. Fi een of these mice were injected intraperitonially with 10 7 RBCs infected with Plasmodium berghei ANKA maintained in 6-8-week-old female Swiss mice. e remaining ve mice served as uninfected controls. Rectal temperature of the infected mice was measured twice a day. CM and NCM were determined based on rectal temperature and neurological symptoms of mice. Mice with rectal temperature <34°C accompanied by neurological symptoms like ataxia and paralysis were considered CM, as reported previously [22, 24] .
Glucose Injection.
A bolus of 125 µL of 1.2M [1-13 C] glucose was injected intravenously into uninfected control mice and mice with CM and NCM at day 9 postinfection. A er 20 min, the animals were sacri ced followed by dissection of brain and liver. e organs were snap frozen immediately a er collection and stored at −80°C till further processing. e 20 minutes timepoint was chosen based on a pilot experiment (Supplementary S1) that showed optimum NMR signals of glucose metabolites between 30 and 40 min. in Mice. In a separate experiment with 12 mice (4 controls) a bolus of 125 µL of 1.2 M [1-13 C] 2-DOG was injected intravenously in mice with CM, NCM and uninfected control animals at day 9 post-infection. A er 20 minutes they were sacri ced, and their brain were dissected out and snap frozen immediately.
2-Deoxyglucose Injection
Tissue Extraction of Brain and Liver.
Brain and liver were subjected to methanol/water/chloroform extraction as described before [25] . Brain and liver samples were weighed and transferred to a glass homogenizer. e tissue was homogenized with ice cold methanol (4 ml/g wet weight) and ice-cold water (0.85 ml/g wet weight). To the homogenate 2 ml/g of chloroform was added and vortexed.
is was followed by the addition of 2 ml/g of water and chloroform and vortexing. e homogenate was allowed to rest for 15 minutes on ice and centrifuged at 1000g. e supernatant was dried in a vacuum concentrator and stored at −20°C until further use for NMR experiments. e dried mass was reconstituted in D 2 O containing TSP for NMR spectra acquisition.
2.6. NMR Experiments. 13 C { 1 H-decoupled} NMR spectra of brain and liver extracts were acquired in 700 MHz spectrometer equipped with a triple resonance broad band inverse probe. e acquisition parameters were as follows, spectral width 218 ppm, data points 64 k, number of transient 4000, relaxation delay 1s and acquisition time 0.85s per FID. e 1 H decoupling was achieved by WALTZ-16 decoupling sequence. For processing, the co-added FIDs were subjected to an exponential multiplication leading to an additional line broadening of 5 Hz followed by Fourier Transformation. e spectra were manually phased, and baseline corrected. e spectral peaks were quanti ed and normalized with respect to entire spectrum. Data analysis was performed in Bruker TOPSPIN 2.1. Human Metabolome Database (HMDB) (http://www.hmdb.ca) and published literatures [26, 27] were used for peak assignment.
Statistical Analysis.
e data are presented as box plot with line at median. e data are analyzed by ANOVA, with Bonferroni correction. * denotes statistical signi cance of < 0.05.
Results
Development of Cerebral Malaria.
Out of 15 mice, 14 mice survived till day 9, while 1 mouse died during experiment. 7 mice developed CM symptoms and exhibited rectal temperature <34°C. e symptoms exhibited by CM in icted mice were ataxia, paralysis, seizures, etc. 6 mice were considered NCM. 1 mouse was kept out of analysis, (borderline rectal temperature). e parasite load was between 20% and 25% when the mice were sacri ced.
Downstream Product Formation from [1-13 C]
Glucose. [1-13 C]-Glucose is metabolized to [3-13 C]-pyruvate that enters TCA cycle via two possible routes -pyruvate dehydrogenase (PDH) and pyruvate carboxylase (PC) pathway. e ow of 13 C from glucose into downstream metabolites is described in Figure 1 . e labeling pattern of metabolites depends on the relative contribution of the metabolic pathways involved. Brie y, [1-13 C] glucose is converted to [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] 
Alterations in Cerebral Glucose
Utilization. Representative 1-dimensional 13 C-NMR spectrum from brain extract of a control mouse postlabeled glucose injection is shown in Figure 2 . Although not as information rich as 1 H NMR due to relative insensitivity, the spectrum identi es key energy metabolites with isotopomer level information. Interestingly, no 13 C multiplets were detected. Speci cally, we detected lactate (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) C), glutamine (3-13 C, 4-13 C, 2-13 C), GABA (2-13 C), glutamate (3-13 C, 4-13 C, 2-13 C), and aspartate (3-13 C, 2-13 C). Normalized intensities of the detected peaks were analyzed and shown in Figure 3 . Signi cant di erences with respect to control animals were observed in the following isotopomers [3-13 C]-lactate was elevated ( < 0.05), while all three detected isotopomers of glutamate and [2-13 C]-GABA were decreased ( < 0.05). e ratio of [4-13 C] to [2-13 C]-was not signi cant in any malaria in icted groups. Interestingly, none of the isotopomers were di erentially altered in CM animals compared to NCM.
Further inspection of the spectra suggested residual [1-13 C]-glucose signals in the brain extracts of CM and NCM animals, while the controls had none (Figure 4 ). We sought to investigate whether this di erence is a result of altered glucose transport or downstream utilization. 
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is altered in malarial infection. P. falciparum infection has been shown to alter glycolytic ux in the nonparasitized RBCs from infected RBC culture [28] . Further studies have demonstrated that speci c host metabolic reprogramming is needed for the sustainability of the parasite [29, 30] . In addition to this, dietary alterations, such as high fat diet and caloric restrictions, have been shown to modify the e ects of P. falciparum infection [31] . Further, inhibition of glycolysis confers protection from CM [32] . Glucose is the primary dietary source of energy in brain.
us, changes in substrate utilization postglucose challenge may provide clues about speci c metabolic reprogramming in CM. In this study of tracking the ow of 13 C label into various metabolites a er the injection of [1-13 C] glucose in CM, NCM, and control mice, some important observations were made. Both groups of malaria in icted mice exhibited a relative increased glycolytic activity, discernable by formation of (2-DOG) was injected into the animals and the levels were checked using 13 C NMR. No signi cant di erences ( Figure 5 ) were observed suggesting depletion in downstream ux, primarily through TCA cycle, leadings to the residual glucose signals. Figure 2 shows a representative 13 
Alterations in Hepatic Glucose Metabolism.
Discussion
Alterations in glucose metabolism are a hallmark of malarial infection. e parasite utilizes host resources, including glucose, to sustain its life cycle. erefore, host glucose metabolism TCA cycle ux compared to control mice might indicate a reduced production of ATP in the brain of both CM and NCM mice, however, this observation needs further validation. Moreover, the relative operation of two routes (PDH and PC) of the entry of pyruvate into TCA cycle is similar in all three classes of animals namely CM, NCM, and control. is is clear from the ratio of C4-/C2-glutamate in the brain. Further, from our study, it is also clear that metabolism of glucose is reduced in both CM and NCM. Brain is a much less e cient glucogenic organ than liver. Malarial infection perhaps reduce brain glucose utilization to avoid a state of hypoglycemia which perhaps is a host response to modulate the disease manifestations [32] . e neurological symptoms of malaria did not a ect the downstream utilization of glucose with respect to normal malaria.
is result corroborates with our previously published results [14] demonstrating no di erence in molecular ngerprints of brain glucose in CM and NCM.
Also, an important conclusion from the experiment is that the glucose transport is not perturbed in CM and NCM elevated lactate, with respect to control while a relatively reduced ux via TCA cycle, indicated by reduced amounts of 13 C label in all the three isotopomers (C2, C3, and C4) of glutamate. ese observations are not dependent on di erential glucose transport across to brain across malarial groups (CM and NCM) and controls, suggested by similar 2-DOG levels in brain of the three groups of mice, implying only the downstream metabolism of glucose is altered in malaria infection.
In malarial group, increased production of lactate from pyruvate could thus result in relatively reduced ux towards TCA cycle as it is the feed to TCA cycle. In this regard, a recent literature reported rescue of CM in mice by targeting glutamine metabolism [29] . is can be due to altered glutamine formation due to TCA cycle ux. e lactate levels and levels of various isotopomers of glutamate are not di erent in CM and NCM, suggesting that the uxes through anaerobic and aerobic pathways were not di erent in the two groups of infected animals. A relatively reduced 
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C NMR spectrum of liver harvested a er 13 C glucose bolus injection in mice. Liver is harvested at different time points a er bolus injection to understand the optimum time point. (Supplementary Materials) compared to controls as there is no difference in the uptake of 2-DOG in brain of CM, NCM and control mice. e difference in the levels of glucose in CM/NCM w.r.t controls is due to perturbation in its downstream utilization. e presence of the unutilized glucose has been reported for the CM and not the NCM [33] . However, the parasite used in that study was P. berghei K173 for NCM. us, this study suggests that glucose utilization is also dependent on the nature of parasites used for the study.
Hepatic glucose utilization in cerebral malaria is virtually unexplored. However, systemic glucose utilization is known to be altered during cerebral malarial complications [23] . e study of the metabolite pool in the liver suggests an increased glucose utilization as evidenced from lower levels of residual [1-13 C] glucose. e increased levels of labelling in lactate and alanine suggest that there is enhanced anaerobic glycolysis in liver of both CM and NCM inflicted animals. Alanine is formed from pyruvate by the action of alanine transaminase. Increased concentration of pyruvate, therefore, leads to the formation of alanine in the case of both CM and NCM. erefore, elevated systemic glycolysis in malaria is also partly due to altered hepatic glucose utilization.
Overall, we observed significantly impacted glucose metabolism postmalarial infection; however no significant difference of glucose utilization by the liver and brain of CM and NCM was observed. It is to be noted, however, that these experiments mimic a condition of glucose challenge and do not reflect steady state glucose utilization, which could be dependent on the cerebral status of the infection.
We should also note the limitation of our study. Specifically, the experimental design did not allow us to separate metabolite of parasite and host origin. Nevertheless, due to the relatively insensitive nature of NMR, detection of metabolites from parasites is unlikely. is is particularly true for liver metabolites since parasite load is comparable between CM and NCM groups.
Conclusion
Malaria significantly alters tissue level glucose utilizations post glucose challenge. Specifically, brain glycolysis seems to be elevated while TCA cycle decreases. Hepatic glycolysis is also elevated, which could regulate systemic glycolysis as well. However, no differential effects were observed between CM and NCM animals. Further investigation of steady state glucose utilization may shed light into the link between glucose metabolism and cerebral malaria.
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